Woods Lori A's Form 4/A amendment
AmendedPerspective Therapeutics, Inc. (CATX) · filed Jun 5, 2024
- Accession no.
- 0000950170-24-069070
- Filed
- Jun 5, 2024
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jun 4, 2024
This filing lists no transactions. It carries over 1 transaction from the original filing that it did not restate. Open-market purchases total $50.0K.
This amendment restates part of 0000950170-24-068638 (filed Jun 4, 2024). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Woods Lori ACIK 0001393007 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0000950170-24-068638 (filed Jun 4, 2024).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2024 | Common Stock | PPurchaseAcquired | +34,246 | $1.46 | +$49,999.16 | 1,553,984 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
This amendment has no footnotes.